PubRank

Pranela Rameshwar

Author PubWeight™ 99.90‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 2011 2.31
2 Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003 2.21
3 Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 2007 1.89
4 Bone marrow failure following severe injury in humans. Ann Surg 2003 1.82
5 Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 2006 1.79
6 Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 2010 1.76
7 Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002 1.58
8 Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids 2013 1.38
9 Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1 alpha. Stem Cells 2005 1.37
10 MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci U S A 2007 1.32
11 Immunological properties of mesenchymal stem cells and clinical implications. Arch Immunol Ther Exp (Warsz) 2008 1.28
12 Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells. J Biol Chem 2009 1.22
13 Mesenchymal stem cells in early entry of breast cancer into bone marrow. PLoS One 2008 1.22
14 Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells 2007 1.20
15 The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma 2005 1.18
16 An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells. Stem Cells Dev 2007 1.16
17 Adrenergic modulation of erythropoiesis following severe injury is mediated through bone marrow stroma. Surg Infect (Larchmt) 2004 1.15
18 Facilitating role of preprotachykinin-I gene in the integration of breast cancer cells within the stromal compartment of the bone marrow: a model of early cancer progression. Cancer Res 2004 1.15
19 β-blockade protection of bone marrow following trauma: the role of G-CSF. J Surg Res 2011 1.06
20 Dose-response relationship between norepinephrine and erythropoiesis: evidence for a critical threshold. J Surg Res 2010 1.06
21 Role of human HGFIN/nmb in breast cancer. Breast Cancer Res 2007 1.06
22 Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc Natl Acad Sci U S A 2005 1.05
23 RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells. Proc Natl Acad Sci U S A 2009 1.05
24 Enhancing effect of IL-1alpha on neurogenesis from adult human mesenchymal stem cells: implication for inflammatory mediators in regenerative medicine. J Immunol 2007 1.05
25 Does beta blockade postinjury prevent bone marrow suppression? J Trauma 2011 1.04
26 SDF-1alpha regulation in breast cancer cells contacting bone marrow stroma is critical for normal hematopoiesis. Blood 2006 1.03
27 Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury. J Trauma 2010 1.03
28 Beta-blockade prevents hematopoietic progenitor cell suppression after hemorrhagic shock. Surg Infect (Larchmt) 2011 1.02
29 Mesenchymal stem cells in drug/gene delivery: implications for cell therapy. Ther Deliv 2012 1.02
30 Brain-derived neurotrophic factor facilitates maturation of mesenchymal stem cell-derived dopamine progenitors to functional neurons. J Neurochem 2009 1.01
31 Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P. Regul Pept 2003 1.00
32 Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J Allergy Clin Immunol 2011 1.00
33 Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells. Cancer Res 2004 0.99
34 Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 2004 0.98
35 A paradoxical role for IFN-gamma in the immune properties of mesenchymal stem cells during viral challenge. Exp Hematol 2005 0.97
36 A theoretical simulation of hematopoietic stem cells during oxygen fluctuations: prediction of bone marrow responses during hemorrhagic shock. Shock 2004 0.95
37 Bone marrow failure in male rats following trauma/hemorrhagic shock (T/HS) is mediated by mesenteric lymph and modulated by castration. Shock 2006 0.95
38 G-coupled protein receptors and breast cancer progression: potential drug targets. Mini Rev Med Chem 2007 0.94
39 Stromal derived growth factor-1alpha as a beacon for stem cell homing in development and injury. Curr Neurovasc Res 2005 0.94
40 Dopaminergic neuronal differentiation protocol for human mesenchymal stem cells. Methods Mol Biol 2011 0.94
41 A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res 2013 0.93
42 Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep 2012 0.92
43 Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells. J Biol Chem 2007 0.91
44 AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells. Am J Cancer Res 2011 0.91
45 Stem cells and regenerative medicine: accomplishments to date and future promise. Ther Deliv 2010 0.90
46 Exogenous CXCL12 activates protein kinase C to phosphorylate connexin 43 for gap junctional intercellular communication among confluent breast cancer cells. Cancer Lett 2012 0.90
47 Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology 2006 0.90
48 Nuclear factor-kappaB is central to the expression of truncated neurokinin-1 receptor in breast cancer: implication for breast cancer cell quiescence within bone marrow stroma. Cancer Res 2007 0.89
49 Breast cancer biology: the multifaceted roles of mesenchymal stem cells. J Oncol 2008 0.89
50 Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA. J Immunol 2008 0.88
51 A method to generate human mesenchymal stem cell-derived neurons which express and are excited by multiple neurotransmitters. Biol Proced Online 2008 0.87
52 Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies. Biologics 2008 0.87
53 microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. Curr Cancer Ther Rev 2011 0.86
54 Neurokinin receptors: relevance to the emerging immune system. Arch Immunol Ther Exp (Warsz) 2004 0.86
55 The Microenvironmental Effect in the Progression, Metastasis, and Dormancy of Breast Cancer: A Model System within Bone Marrow. Int J Breast Cancer 2012 0.86
56 Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells. Clin Transl Sci 2011 0.85
57 Peripheral monocytes and CD4+ cells are potential sources for increased circulating levels of TGF-beta and substance P in autoimmune myelofibrosis. Am J Hematol 2006 0.84
58 Loss of RE-1 silencing factor in mesenchymal stem cell-derived dopamine progenitors induces functional maturity. Mol Cell Neurosci 2008 0.84
59 Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish. Stem Cells Dev 2011 0.84
60 Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection. Oncol Rev 2011 0.84
61 Tac1 regulation by RNA-binding protein and miRNA in bone marrow stroma: Implication for hematopoietic activity. Brain Behav Immun 2007 0.84
62 Nuclear factor-kappaB accounts for the repressor effects of high stromal cell-derived factor-1alpha levels on Tac1 expression in nontumorigenic breast cells. Mol Cancer Res 2007 0.83
63 Cancer immunotherapy: accomplishments to date and future promise. Ther Deliv 2013 0.83
64 Immunostimulatory effects of mesenchymal stem cell-derived neurons: implications for stem cell therapy in allogeneic transplantations. Clin Transl Sci 2008 0.83
65 Breast cancer cell dormancy in bone marrow: potential therapeutic targets within the marrow microenvironment. Expert Rev Anticancer Ther 2010 0.82
66 Sex hormones affect bone marrow dysfunction after trauma and hemorrhagic shock. Crit Care Med 2007 0.82
67 Beta Blockade Protection of Bone Marrow Following Injury: A Critical Link between Heart Rate and Immunomodulation. J Bone Marrow Res 2015 0.82
68 An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development. Biol Proced Online 2007 0.82
69 Cloning and characterization of the 5' flanking region of the HGFIN gene indicate a cooperative role among p53 and cytokine-mediated transcription factors: relevance to cell cycle regulation. Cell Cycle 2005 0.82
70 An in vitro method to select malignant cells from surgical biopsies of breast cancer patients. Biol Proced Online 2005 0.81
71 Current advances in the treatment of Parkinson's disease with stem cells. Curr Neurovasc Res 2007 0.81
72 Stromal derived growth factor-1alpha: another mediator in neural-emerging immune system through Tac1 expression in bone marrow stromal cells. J Immunol 2007 0.80
73 Crosstalk between neurokinin receptors is relevant to hematopoietic regulation: cloning and characterization of neurokinin-2 promoter. J Neuroimmunol 2003 0.80
74 Neurokinin receptors as potential targets in breast cancer treatment. Curr Drug Discov Technol 2008 0.79
75 Analysis of the transfer of circulating microRNA between cells mediated by gap junction. Methods Mol Biol 2013 0.79
76 Experimental evidence for bone marrow as a source of nonhematopoietic endometrial stromal and epithelial compartment cells in a murine model. Biol Reprod 2013 0.79
77 Feline bone marrow-derived mesenchymal stromal cells (MSCs) show similar phenotype and functions with regards to neuronal differentiation as human MSCs. Differentiation 2012 0.79
78 Stromal-derived factor-1alpha induces a non-canonical pathway to activate the endocrine-linked Tac1 gene in non-tumorigenic breast cells. J Mol Endocrinol 2008 0.79
79 The anti-proliferative effect of neurokinin-A on hematopoietic progenitor cells is partly mediated by p53 activating the 5' flanking region of neurokinin-2 receptor. Cell Signal 2005 0.79
80 Synergism between fibronectin and transforming growth factor-β1 in the production of substance P in monocytes of patients with myelofibrosis. Leuk Lymphoma 2012 0.78
81 Long-term kindled seizures induce alterations in hematopoietic functions: role of serum leptin. Epilepsy Res 2005 0.78
82 Effects of kindled seizures upon hematopoiesis in rats. Epilepsy Res 2003 0.78
83 The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential. Clin Exp Metastasis 2006 0.78
84 Multi- and inter-disciplinary science in personalized delivery of stem cells for tissue repair. Curr Stem Cell Res Ther 2009 0.78
85 Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells. PLoS One 2013 0.78
86 Stem Cell Transplantation for Hematological Malignancies: Prospects for Personalized Medicine and Co-therapy with Mesenchymal Stem Cells. Curr Pharmacogenomics Person Med 2011 0.77
87 Tachykinins and Neurokinin Receptors in Bone Marrow Functions: Neural-Hematopoietic Link. J Receptor Ligand Channel Res 2010 0.77
88 Effects of hemispheric lateralization and site specificity on immune alterations induced by kindled temporal lobe seizures. Brain Behav Immun 2002 0.77
89 Can breast cancer stem cells evade the immune system? Curr Med Chem 2012 0.77
90 Amygdaloid kindled seizures can induce functional and pathological changes in thymus of rat: role of the sympathetic nervous system. Neurobiol Dis 2005 0.77
91 Adult mesenchymal stem cells in neural regeneration and repair: Current advances and future prospects (Review). Mol Med Rep 2011 0.77
92 Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis. J Neurooncol 2005 0.77
93 Inflammatory mediators: Parallels between cancer biology and stem cell therapy. J Inflamm Res 2009 0.77
94 The immune properties of mesenchymal stem cells. Int J Biomed Sci 2007 0.77
95 Tachykinins and hematopoiesis. Clin Chim Acta 2007 0.77
96 Recent advances and novel approaches in deriving neurons from stem cells. Mol Biosyst 2009 0.76
97 Oncogenic and metastatic properties of preprotachykinin-I and neurokinin-1 genes. Vascul Pharmacol 2006 0.76
98 Non-canonical effects of anthrax toxins on haematopoiesis: implications for vaccine development. J Cell Mol Med 2008 0.76
99 G protein-coupled receptors in haematopoietic disruption. Expert Opin Biol Ther 2006 0.76
100 Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis. J Neuroimmunol 2008 0.76
101 A reporter assay to detect transfer and targeting of miRNAs in stem cell-breast cancer co-cultures. Methods Mol Biol 2012 0.76
102 Development and characterization of a preclinical ovarian carcinoma model to investigate the mechanism of acquired resistance to trastuzumab. Int J Oncol 2012 0.75
103 Tachykinins and hematopoietic stem cell functions: implications in clinical disorders and tissue regeneration. Front Biosci 2007 0.75
104 Is substance P central to the biology of acute lymphoblastic leukemia? Leuk Res 2007 0.75
105 An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells. Exp Cell Res 2012 0.75
106 Delayed differentiation of HL-60 cells following exposure to hypoxia. J Surg Res 2002 0.75
107 Functions and roles of a protein-associated factor. Cell Biochem Biophys 2014 0.75
108 Exploring a stem cell basis to identify novel treatment for human malignancies. J Stem Cells 2011 0.75